أعرض في EDS

PMS21 Cost Analysis of Work and Household Productivity Improvements with Certolizumab Pegol in Patients with NON-Radiographic Axial Spondyloarthritis in Spain

التفاصيل البيبلوغرافية
العنوان: PMS21 Cost Analysis of Work and Household Productivity Improvements with Certolizumab Pegol in Patients with NON-Radiographic Axial Spondyloarthritis in Spain
المؤلفون: N. Espinoza Cámac, M.Á. Casado, R. Ferrando, S. Maratia, M. Echave
المصدر: Value in Health. 23:S596
بيانات النشر: Elsevier BV, 2020.
سنة النشر: 2020
مصطلحات موضوعية: medicine.medical_specialty, business.industry, Health Policy, Public Health, Environmental and Occupational Health, Work (electrical), Physical therapy, Cost analysis, Medicine, In patient, Axial spondyloarthritis, Certolizumab pegol, business, Productivity, medicine.drug
تدمد: 1098-3015
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::3b148e026dc118226619fc4f5d300246
https://doi.org/10.1016/j.jval.2020.08.1152
حقوق: OPEN
رقم الأكسشن: edsair.doi...........3b148e026dc118226619fc4f5d300246
قاعدة البيانات: OpenAIRE
الوصف
تدمد:10983015